Which class of medications is commonly used as anti-inflammatory therapy for inflammatory bowel disease?

Which class of medications is commonly used as anti-inflammatory therapy for inflammatory bowel disease?

• A. Aminosalicylates
• B. Proton pump inhibitors
• C. Beta blockers
• D. Statins

Answer: (A)

Inflammatory bowel disease is treated by targeting intestinal mucosal inflammation, and aminosalicylates are a classic anti-inflammatory option for this purpose, especially in mild to moderate ulcerative colitis. These drugs deliver 5-aminosalicylic acid to the colonic mucosa, where they dampen inflammation by inhibiting inflammatory mediators in the prostaglandin and leukotriene pathways and may also interfere with NF-κB–driven cytokine production. This direct, local action in the colon makes them effective for induction and maintenance of remission with a relatively favorable safety profile, compared with systemic steroids. Older formulations contain a sulfapyridine component that can cause more side effects, but newer 5-ASA preparations are better tolerated. Other classes listed—acid-suppressing agents, beta blockers, and statins—do not address the mucosal inflammation in IBD as their primary action, so they are not used as the main anti-inflammatory therapy for this condition.

Inflammatory bowel disease is treated by targeting intestinal mucosal inflammation, and aminosalicylates are a classic anti-inflammatory option for this purpose, especially in mild to moderate ulcerative colitis. These drugs deliver 5-aminosalicylic acid to the colonic mucosa, where they dampen inflammation by inhibiting inflammatory mediators in the prostaglandin and leukotriene pathways and may also interfere with NF-κB–driven cytokine production. This direct, local action in the colon makes them effective for induction and maintenance of remission with a relatively favorable safety profile, compared with systemic steroids.

Older formulations contain a sulfapyridine component that can cause more side effects, but newer 5-ASA preparations are better tolerated. Other classes listed—acid-suppressing agents, beta blockers, and statins—do not address the mucosal inflammation in IBD as their primary action, so they are not used as the main anti-inflammatory therapy for this condition.